tiprankstipranks
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
10Bullish
5Neutral
7Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Neutral
6Bullish
0Neutral
6Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.47, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 22.70, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 21.84, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Jul 20, 2026, 08:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.02
23.04
23.02
23.04
23.02
23.04
23.02
Fibonacci
23.04
23.04
23.04
23.04
23.04
23.04
23.04

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Jul 20, 2026, 08:55 AM
Period
Simple
Exponential
MA5
22.84Sell
22.88Sell
MA10
23.25Sell
22.97Sell
MA20
22.86Sell
22.70Sell
MA50
21.35Buy
21.84Buy
MA100
20.86Buy
21.43Buy
MA200
21.62Buy
21.50Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 22.97, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 21.43, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 21.35, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 20.86, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 21.62, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Jul 20, 2026, 08:55 AM
Name
Value
Action
RSI (14)
52.11
Neutral
STOCH (9,6)
13.94
Buy
STOCHRSI (14)
24.65
Neutral
MACD (12,26)
0.47
Buy
ADX (14)
23.23
Neutral
Williams %R
-100.13
Buy
CCI (14)
-20.28
Neutral
ATR (14)
0.26
-
Ultimate Oscillator
46.18
Neutral
ROC
0.22
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 52.11, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 23.23, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is -20.28, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 0.22, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 52.11, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.47, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 22.84, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 22.86, which suggests CURE is a Sell.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 21.35, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 21.62, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -100.13, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is -20.28, which suggests CURE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement